The size of any benefit varies between studies
and especially revaluing the local/neighborhood level
instillation of BPC 157 keeps vessel presentation constant and inhibits these stomach, esophagus, and duodenum lesions, whereas standard agents (atropine, ranitidine, omeprazole) only partially improve vessels and lesions
Chronic stress and lack of sleep are well recognized to suppress the immune system
Given the drugs success in tumor penetration, the researchers investigated whether adding immune checkpoint inhibitors to treatment with the drug would be even more effective, taking the brakes off T cells in more than one way at the same time but there was no such improvement
Synthetic thymosin -4 fragment, evaluated in tissue repair pathways